X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB CIPLA UNICHEM LAB/
CIPLA
 
P/E (TTM) x 33.1 44.2 74.8% View Chart
P/BV x 3.5 3.9 90.3% View Chart
Dividend Yield % 0.5 0.3 163.8%  

Financials

 UNICHEM LAB   CIPLA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
CIPLA
Mar-17
UNICHEM LAB/
CIPLA
5-Yr Chart
Click to enlarge
High Rs334622 53.7%   
Low Rs174458 38.0%   
Sales per share (Unadj.) Rs146.9181.9 80.8%  
Earnings per share (Unadj.) Rs11.912.9 92.4%  
Cash flow per share (Unadj.) Rs16.229.3 55.2%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.80.4 212.6%  
Book value per share (Unadj.) Rs105.1155.7 67.5%  
Shares outstanding (eoy) m90.84804.51 11.3%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x1.73.0 58.2%   
Avg P/E ratio x21.442.0 50.9%  
P/CF ratio (eoy) x15.718.4 85.2%  
Price / Book Value ratio x2.43.5 69.7%  
Dividend payout %16.815.5 108.2%   
Avg Mkt Cap Rs m23,073434,516 5.3%   
No. of employees `0005.723.0 24.6%   
Total wages/salary Rs m2,55826,338 9.7%   
Avg. sales/employee Rs Th2,352.56,349.1 37.1%   
Avg. wages/employee Rs Th450.91,143.0 39.4%   
Avg. net profit/employee Rs Th190.4449.3 42.4%   
INCOME DATA
Net Sales Rs m13,346146,302 9.1%  
Other income Rs m1922,287 8.4%   
Total revenues Rs m13,538148,589 9.1%   
Gross profit Rs m1,63924,758 6.6%  
Depreciation Rs m39013,229 2.9%   
Interest Rs m291,594 1.8%   
Profit before tax Rs m1,41212,222 11.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m-4-70 5.3%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2931,798 16.3%   
Profit after tax Rs m1,08010,354 10.4%  
Gross profit margin %12.316.9 72.6%  
Effective tax rate %20.714.7 140.9%   
Net profit margin %8.17.1 114.4%  
BALANCE SHEET DATA
Current assets Rs m5,97987,370 6.8%   
Current liabilities Rs m2,43233,081 7.4%   
Net working cap to sales %26.637.1 71.6%  
Current ratio x2.52.6 93.1%  
Inventory Days Days6387 72.5%  
Debtors Days Days6062 96.9%  
Net fixed assets Rs m6,403111,567 5.7%   
Share capital Rs m1821,609 11.3%   
"Free" reserves Rs m9,293123,645 7.5%   
Net worth Rs m9,548125,254 7.6%   
Long term debt Rs m23036,454 0.6%   
Total assets Rs m12,843209,532 6.1%  
Interest coverage x50.08.7 577.2%   
Debt to equity ratio x00.3 8.3%  
Sales to assets ratio x1.00.7 148.8%   
Return on assets %8.65.7 151.5%  
Return on equity %11.38.3 136.9%  
Return on capital %14.38.5 168.7%  
Exports to sales %29.234.2 85.4%   
Imports to sales %6.38.3 76.1%   
Exports (fob) Rs m3,90050,050 7.8%   
Imports (cif) Rs m84712,203 6.9%   
Fx inflow Rs m4,35651,066 8.5%   
Fx outflow Rs m1,16217,678 6.6%   
Net fx Rs m3,19433,388 9.6%   
CASH FLOW
From Operations Rs m1,11923,824 4.7%  
From Investments Rs m-853-13,127 6.5%  
From Financial Activity Rs m-334-13,239 2.5%  
Net Cashflow Rs m-68-2,478 2.8%  

Share Holding

Indian Promoters % 50.1 16.0 313.1%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 15.1 12.2 123.8%  
FIIs % 3.0 23.7 12.7%  
ADR/GDR % 0.0 1.1 -  
Free float % 31.7 26.2 121.0%  
Shareholders   20,176 161,166 12.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare UNICHEM LAB With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 22, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS